Bills: SB6061 , SB6234 , SB6176 , SB6335 , SB6047 , HB2235 , HB2464 , HB2619 , HB1376 , SB5808 , SB5949 , HB1347 , HB1759 , HB1983 , HB2120 , HB2264 , HB2338 , HB2385 , HB2495 , HB2521 , HB2604 , HB2610 , HB2675 , HB2426

Keywords: tourism, self-supported assessment, funding, statewide promotion, economic development, sewage, grinder pumps, residential buildings, regulation, construction, vehicle registration, enforcement, renewal, transportation, state law, state commission, infrastructure, traffic safety, responsibilities, state capital projects

Summary: The Senate considered Engrossed Second Substitute House Bill 2034, a measure to terminate and restate the LEOFF 1 pension plan and use surplus funds for other state purposes if federal approval is obtained. During debate, senators discussed whether the plan should remain funded at 110% or 120% of actuarial value, whether surplus dollars should instead go to transportation or the budget stabilization account, whether members should receive an additional distribution, and whether local governments should be reimbursed for retiree health care costs. Several amendments were offered: a Gildon amendment to raise the funding target to 120% failed; a technical Robinson amendment adding a date passed; Holy, King, Harris, Schessler, and Conway amendments addressing member distributions, transportation, budget stabilization, local government health care costs, and a reconstituted board distribution all failed; and Robinson’s amendment removing Climate Commitment Act repayment language passed. The Ways and Means striking amendment, as amended, was then adopted. On final passage, supporters argued the bill was actuarially sound, had been reviewed by attorneys, actuaries, the State Investment Board, and the Department of Retirement Systems, and would allow use of excess funding for other state needs. Opponents warned it left too little in the pension fund, should dedicate surplus dollars only to one-time uses, and did not adequately reimburse cities and counties for retiree medical obligations. After debate, the Senate passed E2SHB 2034 by a vote of 25 yeas, 22 nays, with one absent and one excused. Afterward, the Senate returned to Substitute House Bill 2178, which was also passed on final passage by a vote of 39 yeas and 9 nays, with one excused. The chamber then adjourned until the next scheduled meeting.

Transcript Highlights:

• Our goal is to eliminate injuries through improvements in workplace safety and preventative strategies
• Right now, some of the ground-floor retail requirements in cities prevent housing development because
• Senate Bill 5520 will reduce unnecessary litigation that prevents innocent people from being trapped
• Out of the 38 opioid recovery centers, 21 of them are owned by the Washington tribes.
• Concern combat in the opioid crisis that we have.

Bills: SB5420 , SB5877 , SB5868 , SB5109 , SB5832 , SB5922 , SB5944 , SB5988 , SB6065 , SB6103 , SB6151

Committee: House Appropriations

Keywords: veterans, military spouses, service members, uniformed services, National Guard, reservists, active duty, qualifying discharge, veterans preference, hiring preference, public employment, state benefits, license renewal, professional licensing, retirement service credit, pension, public retirement system, Washington RCW, military leave, reemployment rights

Transcript Highlights:

• Health care services with an A or B recommendation from the United States Preventive Services Task Force
• , preventive health care services described by 45 CFR Section 147.130, and health care services provided
• HB 476 seeks to prevent discrimination against individuals seeking organ transplants in Texas based solely
• Additionally, the bill allows funds from the opioid abatement account established under the statewide
• opioid settlement to be appropriated to support the MOM model.

Bills: HB163 , HB216 , HB721 , HB2035 , HB2038 , HB3057 , HB3153 , HB3233 , HB3595 , HB3801 , HB3812 , HB4076 , HB4129 , HB4377 , HB4535 , HB4666 , HB4730 , HB4743 , HB4903 , HB5149 , HB5155 , HB1534

Committee: Senate Health & Human Services

Keywords: epinephrine, healthcare, emergency response, administration, medical policy, health care, itemized billing, patient rights, provider regulations, Texas Health and Safety Code, cost disclosure, insurance, benefit plan, administrators, chemical dependency, treatment facilities, minor admissions, parental notice, mental health, medical licensing

Summary: The committee met without a quorum at first, then established a quorum with five members present. Members heard and left pending several House bills, including HB 4743 on allowing hospitals to license mobile stroke units under a hospital license, HB 4129 on earlier DFPS enforcement tools for single-source continuum contractors in community-based foster care, HB 4903 creating a Quad Agency Child Care Initiative to coordinate child care regulations across state agencies, HB 3812 revising the gold card/prior authorization process for physicians, HB 4535 requiring written informed consent before COVID-19 vaccination and a standardized state information sheet, and HB 4666 reducing the frequency of some HHSC reports to the legislature. The chair also noted HB 35 would be voted on later after a subcommittee back was received, and that a large number of bills would be heard the next day. Most of the testimony focused on HB 4535 and HB 4730. On HB 4535, supporters argued the bill would strengthen informed consent for COVID vaccination by requiring written consent and clearer state-level information about risks, manufacturer liability protections, and adverse-event reporting; opponents, including a pediatrician and medical groups, said existing federal and state informed-consent materials already cover these topics and warned the bill could create duplicative paperwork and penalties. On HB 3812, the Texas Medical Association supported changes that would extend the gold-card evaluation period to one year, raise transparency, and make prior authorization exemptions easier to administer, while health plans said they were neutral and viewed the bill as a balance between reducing burden and preventing fraud or unsafe care. HB 4730 drew extensive testimony from adoption professionals, birth mothers, adoptive parents, and child welfare advocates. The bill would require DFPS to create a relinquishment form, train child-placing agency staff, and extend the minimum waiting period for voluntary relinquishment from 48 hours to seven days. Supporters of the current law argued the 48-hour period aligns with hospital discharge, allows informed decisions, and helps birth parents and adoptive families begin healing and bonding without pushing children into foster care or creating legal and Medicaid complications. The author said the bill would be revised and that the seven-day provision was a work in progress. No votes were taken on the bills during the meeting; each bill was left pending after public testimony closed.

Transcript Highlights:

• Was the death preventable?
• and access to non-opioids.
• And so I think... ...when an opioid-naive patient is treated with opioids.
• And unfortunately, as it stands, opioids or short-acting opioids come up quite often.
• versus opioids.

Committee: Joint Health Care Committee

Summary: The committee first approved the minutes and then heard a detailed annual presentation from Dr. Thomas Arnold, chair of the Maternal Mortality Review Committee, on maternal mortality trends and review findings. He explained the committee’s structure, the de-identified review process, and the distinction between pregnancy-associated and pregnancy-related deaths. He said national maternal mortality has declined from its 2021 peak, but mental health conditions, substance use, overdose, suicide, cardiovascular disease, hemorrhage, infection, and embolism remain major causes. He emphasized that many deaths are preventable, with especially high rates among non-Hispanic Black women and in the American Indian/Alaska Native population, and noted that a large share of deaths occur after 42 days postpartum. Committee members asked about suicide, domestic abuse, pregnancy testing in unexplained deaths, and the role of home births and midwife training. Dr. Arnold said the committee is adding a caseworker, exploring post-mortem pregnancy testing in suspicious cases, and working with coroners and forensic officials; he also said home births and untrained midwifery pose safety concerns and that better public education and facility-based care are important. The committee then heard from State Fire Marshal Dr. Matt Clark on cigarette ignition propensity standards and fire prevention. He recommended updating North Dakota’s cigarette ignition legislation to the current national standard and also considering legislation requiring fast-breakaway oxygen tubing, citing fatal fires involving smoking around home oxygen. He explained that his office verifies manufacturer testing and maintains certification for cigarettes sold in the state, but does not itself conduct the testing. Members asked about implementation, cost, and whether the standards apply in tribal communities; Clark said he would follow up with cost information and additional details, and that he had not seen evidence of a major issue on tribal lands but would look further. Christine Greff of the Department of Health and Human Services presented the North Dakota Stroke System of Care report. She described the statewide network of two comprehensive stroke centers, four primary stroke centers, and 30 acute stroke-ready hospitals, along with the stroke registry and quality-improvement efforts. She reported that most strokes are ischemic, that the median stroke patient age is 71.5, and that common risk factors include hypertension, dyslipidemia, obesity, and diabetes. She highlighted improvements in door-to-CT, thrombolytic treatment times, dysphagia screening, EMS pre-notification, and interfacility transfer performance, and said new priorities include hemorrhagic stroke quality measures and standardized EMS stroke screening tools. Members asked about the VA hospital’s participation, and Greff said she would pursue outreach. After a break, the committee heard testimony from Taha Khan of Vertex Pharmaceuticals as part of the prior authorization study, focused on non-opioid pain treatment. He argued that prior authorization can delay access to acute pain treatment and may push patients toward opioids, especially in the critical 24- to 72-hour post-discharge window. He cited data showing that even short opioid exposure can increase the risk of long-term use and said prior authorization is often a barrier for physicians and patients. Khan recommended open access with a quantity limit rather than prior authorization, suggesting a 14-day limit supported by the product’s data and an episode-of-care approach. Members asked about dental use, payer discussions, and cost; he said the product’s wholesale acquisition cost is about $16.10 per tablet, with patient assistance available, and that he would follow up on payer and comparison-cost questions.

Transcript Highlights:

• Was the death preventable?
• and the risks, a lot of times you'll hear things like opioid-naive and opioid-exposed.
• And so I think— When an opioid-naive patient is treated with opioids.
• And unfortunately, as it stands, opioids or short-acting opioids come up quite often.
• versus opioids.

Summary: The committee first approved the previous meeting minutes and then heard a detailed annual report from Dr. Thomas Arnold, chair of the Maternal Mortality Review Committee, on maternal mortality trends and policy issues. He explained the committee’s review process, confidentiality protections, and national and North Dakota data showing that most maternal deaths are preventable and that mental health conditions, substance use, cardiovascular issues, infection, hemorrhage, and embolism are the leading causes. Members asked about suicide, domestic violence, midwife training, home births, and whether pregnancy testing at death scenes should be expanded; Dr. Arnold said better coroner education, more investigation of unexplained deaths, and possible post-mortem pregnancy testing could improve case identification, especially in rural areas. He also noted that deaths often occur well after 42 days postpartum and that mental health-related deaths remain a major concern. The committee then heard from State Fire Marshal Dr. Matthew Clark on cigarette reduced-ignition-propensity standards and related fire prevention issues. He recommended updating the state’s cigarette propensity law to current national standards and also raised a separate recommendation to require fast-breakaway oxygen tubing for home oxygen users, citing fatal fires linked to smoking around oxygen. Members asked about implementation, cost, insurance coverage, and whether the standards apply in tribal communities; Dr. Clark said he would provide follow-up information and was willing to help with any legislation, but no agency bill had yet been planned. Next, Christine Greff of the Department of Health and Human Services reported on the North Dakota Stroke System of Care. She described the statewide network of stroke-ready hospitals, registry-based quality improvement, and performance data showing continued improvement in stroke recognition, imaging, thrombolytic treatment, transfers, and EMS pre-notification. She highlighted new quality measures for inter-facility transfers and intracerebral hemorrhage care, and said the system remains strong but depends on continued legislative and hospital support. Committee members asked about participation by the VA hospital and were encouraged to consider outreach to include it more fully in the stroke system. Finally, the committee began a presentation on prior authorization and non-opioid pain treatment from Taha Khan of Vertex Pharmaceuticals. He argued that prior authorization can delay access to non-opioid acute pain medications, especially in the 24- to 72-hour post-discharge window when pain is most severe, and said delays can push patients toward opioids. He emphasized that prior authorization has a role in utilization management but should not create barriers in acute pain care, and he noted that current use of the company’s non-opioid product remains very low. The discussion was still underway when the transcript ended.

Transcript Highlights:

• A few of them are opioid medications for opioid use disorder, overdose prevention, first responder support
• </c> opioid uh disorder. opioid uh disorder.
• prevention, overdose prevention.
• </c><00:55:08.160><c> prevention,</c><00:55:08.880><c> overdose</c> and opioid prevention, overdose and
• opioid prevention, overdose prevention.<00:55:10.240><c> So,</c><00:55:10.400><c> it</c><00:55:10.559

Keywords: 1189, house, all

Summary: The committee met on January 23, 2026, to approve prior minutes and receive an update from the Department of Health and Human Services. The main presentation focused on “Project Compass,” an internal cross-department effort to prepare for changes to Medicaid and SNAP eligibility. Department staff said the goal is to maintain continuous coverage for eligible people, align policy, operations, communications, legal, finance, and eligibility work, and use the new integrated New HEIGHTS system to streamline implementation. They emphasized outreach to beneficiaries, providers, managed care organizations, and other partners, and said temporary manual workarounds had already been used to stay in compliance with fast-moving SNAP changes. Members questioned how the department would avoid repeating the costly outreach effort used in a prior Medicaid work-requirement rollout. Department officials said they are focusing on ex parte processes, sharing eligibility information across programs, and using community partners to reduce duplicate contacts and paperwork. They also said the department is monitoring the SNAP error rate closely, expects automation and a planned system contract amendment to help reduce it, and noted that current error rates are trending downward and remain below the national average. Questions were also raised about possible future SNAP restrictions on certain foods; the department said it can implement whatever the legislature directs, but that defining and administering such restrictions would be complex. The commissioner and CFO then outlined the department’s budget reduction plan. They said the department has begun implementing required “back of the budget” reductions for fiscal year 2026, using contract savings and not cutting existing services where possible. Examples included dental and home-visitation contracts, where spending was adjusted based on utilization and projected need. Officials said they had already written down a little over $15 million in prior-year encumbrances, but that this one-time source will not be available next year, making fiscal year 2027 more difficult. They also explained the difference between legally required back-of-budget cuts and lapse, and said staffing remains a major challenge because vacancies have increased and customer-facing service levels are strained. Dr. Jonathan Ballard then began an update on opioid overdose fatalities, presenting the latest medical examiner data and describing the long-term rise in deaths after fentanyl entered the illicit drug supply, with a peak in 2017 and a later increase in 2022. The transcript cuts off before his full presentation and any further committee action beyond discussion of the minutes and receipt of the department updates.

Transcript Highlights:

• This shows the outcomes for prevention. shows the outcomes for prevention.
• So prevention, treatment, recovery — all of those.
• It's not just prescription opioids, as you all know.
• Are you trying to prevent people from ever using opioids wrongly, or are you trying to target people
• center. the dedicated opioid treatment center.

Keywords: 924, joint, all

Transcript Highlights:

• So the bill's mechanism, by tying non-opioid utilization controls to the least restrictive opioid standard
• of opioids.
• of opioids.
• The current non-opioids we cover cost $10, whereas this new non-opioid, Drenavics, costs around $360.
• Opioids are not a part of my story.

Bills: HB2048 , HB2189 , HB2248 , HB2403 , HB2728 , HB2729 , HB2730 , HB2731 , HB2906 , HCR2058

Committee: Senate Health and Human Services

Keywords: orders of protection, domestic violence, court procedures, legal guardian, enforcement, healthcare, licensed health aides, scope of practice, ventilator care, training standards, medical freedom, healthcare mandates, employment requirements, public health, government regulation, elderly, physical disabilities, Arizona Health Care Cost Containment System, home and community based services, funding increase

Transcript Highlights:

• The decline in opioid overdose deaths, as you know, is a prevention story too. As Dr.
• The decline in opioid overdose deaths, as you know, is a prevention story, too. As Dr.
• Correct, for treatment and prevention.
• And so across the nation, we're seeing that many overdose deaths are not just opioids; they're opioids
• We can't give them opioids.'

Committee: House Substance Abuse Prevention and Treatment Task Force

Keywords: 959, house, all

Transcript Highlights:

• So the bill's mechanism, by tying non-opioid utilization controls to the least restrictive opioid standard
• of opioids.
• The current non-opioids we cover cost $10, whereas this new non-opioid, Drenavics, costs around $360.
• Opioids are not a part of my story.
• Opioids are not a part of my story.

Committee: Senate Senate Health and Human Services COR

Summary: The committee first approved the March 11 minutes and heard a presentation from Nathan Smith, CEO of Central Arizona Shelter Services, on homelessness in Maricopa County. He described rising homelessness, especially among older adults, and said CASS uses low-barrier emergency shelter, family shelter, and an older-adult shelter with case management, behavioral health services, and partnerships with outside groups for food, banking, digital access, and other supports. Members asked about collaborations with mutual aid groups and about point-in-time data, and Smith said the county data could be drilled down through AZMAG. The committee then moved to legislation. HB 2248, the Arizona Medical Freedom Act, would bar businesses, schools, and government entities from denying services or employment based on medical interventions, with an amendment allowing schools to limit access during outbreaks or for certain infections. Supporters framed the bill as protecting bodily autonomy and informed consent, while opponents argued it would undermine employers’ ability to prevent disease spread. The committee adopted the amendment and gave the bill a due pass recommendation on a 4-3 vote. HB 2906, requiring one dental board member to be an active oral and maxillofacial surgeon, passed unanimously after testimony that the board needs surgical expertise for complex cases and anesthesia oversight. HB 2189, directing the Nursing Board to adopt rules for licensed health aides and routine ventilator care, also passed with an amendment and a 6-0 vote. HB 2403 appropriates $2.5 million in FY2027 for home and community-based services providers for elderly and physically disabled Arizonans. Supporters said the funding would help retain caregivers, whose wages have lagged for years, and argued home care is cheaper than hospitalization or institutional care; the bill passed 6-0. HB 2731 continued the Physician Assistant Board to 2030 and passed with a technical amendment, and HB 2730 continued the Occupational Therapy Board and passed as well. HB 2729 continued the Nursing Board to 2030; the board said it regulates about 150,000 licensees and handles thousands of complaints annually, and the bill passed 6-0. HB 2728 continued the Department of Economic Security and incorporated several previously vetoed policy provisions affecting SNAP, unemployment, and eligibility/redetermination rules. Speakers in opposition said it would make benefits harder to access and turn a continuation bill into a vehicle for controversial policy changes, while supporters argued it was part of the legislature’s oversight role. The bill passed 4-3. The committee also adopted a strike-everything amendment to HB 2048, which limits utilization controls on FDA-approved non-opioid pain medications relative to opioids; supporters said it would improve access to non-opioid pain treatment and reduce opioid harm, while opponents warned it would bypass clinical review and raise costs. HB 2048 passed 4-3. Finally, HCR 2058 would require a comprehensive claim-level audit of Arizona Medicaid claims and direct recovery efforts for misappropriated funds; supporters said it could recover significant overpayments, while opponents questioned its incentives and overlap with existing oversight. The resolution passed 4-3, and the committee adjourned.

Transcript Highlights:

• The proper use of the opioid settlement fund dollars as compared with the substance misuse prevention
• settlement fund belongs for opioid settlement prevention.
• So, if the money for the opioid settlement overdose prevention center is not used, it can be reverted
• So, if the money for the opioid<01:03:12.440><c> settle</c> opioid settle opioid settle overdose<01:03
• :14.520><c> prevention</c><01:03:15.000><c> center</c> overdose prevention center overdose prevention

Keywords: 927, senate, all

Transcript Highlights:

• Okay, so opioids. Incredibly sick from their use. Okay, so opioids.
• The decline in opioid overdose deaths, as you know, is a prevention story, too. As Dr.
• Correct, for treatment and prevention.
• He's struggling with opioid disorder.
• We can't give them opioids.”

Committee: House Substance Abuse Prevention and Treatment Task Force

Summary: The task force meeting opened with a brief organizational update, including new leadership, roll call, and an explanation of the task force’s statutory duties: to study current and future drug and substance use in Missouri, explore solutions, draft or modify legislation, and report recommendations on prevention and treatment. The chair outlined the summer hearing plan, which would feature field experts, with future sessions expected to cover alternative therapies such as psilocybin and ibogaine and testimony from the Department of Mental Health. Members were encouraged to think about legislative ideas and policy recommendations for the upcoming session. The first major testimony came from Dr. Rachel Winograd, who described Missouri’s overdose crisis as evolving into a “fourth wave” marked by fentanyl mixed with animal tranquilizers such as xylazine and medetomidine, along with methamphetamine and other synthetic drugs. She said overdose deaths have declined for a third straight year, with preliminary 2025 data around 1,200 deaths, but emphasized that the crisis remains severe. Her main recommendations were to focus on demand reduction rather than repeated supply crackdowns, expand evidence-based treatment—especially methadone and buprenorphine—broaden naloxone access, and improve practical supports like housing, transportation, and case management. She also said peer services are valuable but should not be used as a substitute for clinical care, and noted that Missouri Medicaid generally covers evidence-based treatment but reimbursement for peer recovery services remains a gap. Dr. Heidi Miller, the state medical director at the Department of Health and Senior Services, reinforced the call for integrating substance use disorder care into whole-person health care. She highlighted the state naloxone standing order, which supports more than 11,000 Medicaid naloxone prescriptions annually, and urged five best practices: integrating SUD treatment into primary care, maternal health, general medical training, EMS initiation of buprenorphine after overdose, and expanded methadone access. She also argued for team-based reimbursement, stronger parity enforcement between behavioral health/SUD and physical health, and caution in regulating emerging substances so policy does not outrun the science. Dr. Doug Burgess of University Health in Kansas City echoed the integration theme, arguing that Missouri’s system is too fragmented and that patients are often stabilized and then left to coordinate their own next steps. He compared ideal SUD care to the coordinated response used for heart attacks, with seamless transitions from emergency care to inpatient treatment, rehab, and outpatient follow-up. He said treatment courts can be effective when they are well coordinated and informed by addiction science, and he stressed the importance of discharge planning, peer recovery coaches, information-sharing, and maintaining Medicaid coverage during justice involvement. No formal votes or committee actions were taken during this portion of the meeting.

Transcript Highlights:

• -based coalition dedicated to preventing opioid addiction in the United States.
• -based coalition dedicated to preventing opioid addiction in the United States.
• -based coalition dedicated to preventing opioid addiction in the United States.
• -based coalition dedicated to preventing opioid addiction in the United States.
• -based coalition dedicated to preventing opioid addiction in the United States.

Keywords: 958, all

Summary: The Medicaid Oversight Advisory Board met with a quorum, approved the November 12 minutes by voice vote, and then heard a presentation from former Governor Ernie Fletcher and Dave Johnson on Medicaid reimbursement for substance use disorder (SUD) treatment. Fletcher argued that addiction should be treated as a chronic disease requiring a longer continuum of care, not just short residential stays, and said recovery should combine clinical treatment with social supports such as housing, transportation, employment, peer coaching, and recovery housing. He cited data on overdose trends, low treatment rates, and high costs for people with SUD, and said current reimbursement models create poor incentives and do not adequately support long-term recovery or measure outcomes well. Fletcher proposed a “carve through” model administered at the MCO level with standardized metrics, data sharing, and an independent recovery coordinator that would assess patients, coordinate care, and connect them to clinical and social recovery services. He suggested using bundled payments, shared savings, and partial risk arrangements, with recovery housing reimbursed on a PMPM or weekly basis and funded in part through existing Medicaid spending and other sources such as opioid abatement funds. He also emphasized peer support, telemedicine, criminal justice coordination, workforce and education supports, and the use of technology, including text messaging and possibly AI, to maintain long-term follow-up and identify relapse risk. Members questioned how the model would work in practice, especially the education and staffing requirements for recovery coordinators, reimbursement levels, and how many patients each coordinator or peer would serve. Fletcher said peers could be certified and would need additional training in assessments such as ASAM and recovery residence standards, but he did not give a precise salary figure, saying the market and bundled rates would determine that. He also said follow-up should continue for years, noting relapse risk over the first 18 to 24 months and that meaningful employment and ongoing peer contact help sustain recovery. No formal vote or action was taken on the substance use presentation.

Transcript Highlights:

• That is for the annual grants for prevention, treatment and recovery of opioids, for Auburn University
• That is for the annual grants for prevention, treatment and recovery of opioids, for Auburn University
• , treatment and recovery uh of prevention, treatment and recovery uh of opioids<00:20:26.880><c> for<
• prevention 1.9 education side and prevention 1.9 million.<00:20:32.159><c> I</c><00:20:32.320><c> just
• </c> opioids. So that that's a good positive. opioids. So that that's a good positive.

Bills: HB44 , HB400 , HB444 , HB487 , SB249 , SB252 , SB58 , HB44 , HB400 , HB444 , HB487 , SB249 , SB252 , SB58

Committee: House Ways and Means General Fund

Keywords: teachers retirement, credit purchase, St. Clair County, DAY Program, pension reform, dental insurance, benefit rollover, healthcare, insurance policy, annual maximum, HB444, vaccines, vaccine exemption, religious exemption, religious liberty, private school, church school, faith-based school, parochial school, school immunization

Transcript Highlights:

• on inpatient opioid withdrawal management, offering escalating doses of opioid withdrawal medication
• It's not an opioid.
• It's not an opioid.
• Standard protocol leads us to administer Narcan, which reverses opioid overdoses by binding to opioid
• But this does. the stern Narcan, which reverses opioid overdoses by binding to opioid receptors.

Keywords: 995, all

Summary: The Special Commission on xylazine held its first meeting, with House Chair Mindy Domb and Senate Co-Chair John Keenan outlining the commission’s charge and a proposed work plan. The commission is tasked with studying the public health and safety impacts of xylazine in the illicit drug supply, including whether it should be scheduled as a controlled substance, how to regulate its production and distribution, and how to improve outreach and treatment for people exposed to it. Members were told the report deadline had been extended to March 30, 2026, and staff proposed a series of public hearings and working groups leading to a final report. The meeting also included attendance, packet materials, and procedural planning. The first major testimony came from BSAS Director Deirdre Calvert, who described xylazine’s appearance in Massachusetts drug supply data, the state’s public health alerts, and DPH’s partnership with Brandeis, CDC, and harm reduction organizations. She emphasized four priorities: reducing stigma and discrimination in health care, expanding self-directed wound care support and coverage for supplies, expanding access to drug checking and test strips, and supporting low-barrier services such as mobile vans and drop-in centers. Commission members asked about first responder awareness, medical education, and whether harm reduction services might face federal restrictions; Calvert said misinformation remains a problem and noted ongoing training efforts, including collaboration with public safety agencies. Several other speakers reinforced the need for low-barrier care and drug checking. Dr. Raghini Jala, an infectious disease and addiction medicine physician, said xylazine has become a common component of the unregulated opioid supply and urged support for rapid-response education teams, community-based drug checking, and better hospital and detox protocols for xylazine withdrawal and wounds. Recovery coach Alan Young testified from lived experience, describing severe wounds, fear of inadequate withdrawal treatment in emergency settings, and the value of mobile care vans that can provide methadone, buprenorphine, and wound care in the community. Dr. Sarah Wakeman echoed the need for naloxone, rescue breathing, low-threshold treatment, and non-stigmatizing health care settings, while Sarah Macon of the Boston Public Health Commission described Boston’s harm reduction and drug checking work, including on-site testing, wound care, and a decline in opioid mortality. Tracy Green of the Massachusetts Drug Supply Data Stream explained that xylazine has declined in recent samples while metatomidine is rising, said drug checking is increasingly used but still not enough, and argued for more funding, staffing, and statewide access to real-time drug checking and harm reduction services.

Transcript Highlights:

• Thank you, Madam Chair, and thank you, President Fermi. substance use and opioid prevention.
• both primary and tertiary prevention, to prevent people from dying of overdose and from developing substance
• or possibly having an opioid use disorder.
• ERO dollars from our local opioid funding.
• We also know that good prevention, really effective upstream prevention, costs less than treatment.

Committee: House Legislative Health & Human Services Committee

Transcript Highlights:

• As some background, opioids are a class of drugs that bind to opioid receptors in the body to reduce
• It is still far easier to prescribe an opioid than to offer safe, effective non-opioid alternatives.
• on non-opioid pain treatments than on opioids, or designate non-opioids as non-preferred while opioids
• on non-opioid pain treatments than on opioids, or designate non-opioids as non-preferred while opioids
• It cannot designate non-opioids as non-preferred while opioids remain preferred.

Summary: The Senate Health and Long-Term Care Committee heard testimony on several bills. SB 6159 would create a public hospital infrastructure account funded by a new annual coverage assessment on insurers and other businesses subject to the premium tax, and would allow public hospital districts and other public health entities to collaborate more freely and access capital financing for major construction or modernization projects. Senator Dhingra said the bill is intended to help public hospitals compete and modernize, especially amid federal Medicaid and ACA subsidy cuts. Supporters included UW Medicine, while hospital districts supported the general concept but said Section 2 could unintentionally narrow existing cooperative agreements with nonpublic entities. Health plans and insurers opposed the bill, arguing it would raise premiums, increase consolidation, and improperly sweep in property and casualty insurers and mutual companies; testimony also raised concerns about pass-through costs and retaliatory tax effects. The hearing on SB 6159 closed with 5 pro, 74 con, and 2 other sign-ins. The committee then heard SB 5845, which would modernize timely payment rules by requiring carriers and public employee plans to pay or deny all clean claims within 30 days, require prompt notice and a single request for additional information on incomplete claims, and impose interest or penalties for missed deadlines. Senator Slaughter said the bill would reduce uncertainty for providers and stabilize payments without increasing patient costs. Hospitals, physicians, and health systems strongly supported the measure, citing large volumes of late clean claims and examples of prolonged delays, including a Harborview claim that remained unpaid more than a year after billing. Health plans opposed the bill, saying the current 95% standard is workable, that they already meet high compliance rates, and that the bill could limit fraud, waste, and abuse review on high-dollar claims; they also sought more flexibility and additional time for responses. The hearing closed with 69 pro, 4 con, and 2 other sign-ins. The committee also heard SB 5916, which would prohibit health plans from disadvantaging non-opioid pain treatments relative to opioids in formularies and utilization management, and would require a Department of Health educational pamphlet on non-opioid alternatives. Senator Harris described the bill as a response to opioid deaths and a way to encourage safer pain treatment options. Patients, recovery advocates, and rare disease advocates testified in support, saying insurance barriers and step therapy often make non-opioid care harder to access and can push patients toward opioids. The Health Care Authority and an association of health plans opposed the bill, arguing it could reduce formulary flexibility, increase costs, and limit tools such as prior authorization and step therapy. The hearing closed with 8 pro, 1 con, and 2 other sign-ins. Finally, the committee heard SB 6102 and SB 6103, both sponsored by Senator Muzzall, and SB 6071. SB 6102 would align the ambulance transport quality assurance fee with federal rules after H.R. 1 barred new provider taxes, preserving the existing fee rate and adjusting the Medicaid add-on rate annually; the Washington Ambulance Association supported it, saying the program had improved wages and benefits for EMS workers. SB 6103 would make Medicaid payments for services provided by a rural emergency hospital subject to appropriation, creating a framework for East Adams Rural Health Care to convert to the new federal rural emergency hospital model; East Adams and the Washington State Hospital Association supported it as a way to preserve rural access. SB 6071 would shorten overpayment recovery timelines for all services to six months, or nine months for coordination-of-benefits cases, matching the shorter timelines already enacted for behavioral health services; providers and specialty associations supported the bill as a way to reduce destabilizing clawbacks, while the remaining testimony was still underway when the transcript ended.

Transcript Highlights:

• We can prevent hospitalizations. ...we can prevent costly falls, we can prevent hospitalizations, we
• What this bill will do is level the playing field by ensuring opioid and non-opioids are treated equally
• . on the opioid crisis in 2016, 2017.
• of opioid addiction versus these non-opioid alternatives.
• We agree that when a physician writes a prescription for a non-opioid medication to treat pain, an opioid

Committee: House House Health & Human Services Committee of Reference

Summary: The committee heard testimony on several health-related bills. HB 2726 would require coverage for diagnosis and treatment of mild obstructive sleep apnea, including a tongue-muscle stimulation device. The sponsor and medical witnesses said the device is a less burdensome alternative to CPAP and could improve adherence and reduce long-term complications, while Access said it already covers medically necessary sleep apnea treatment but was neutral and concerned the bill could narrow review and limit cost-effectiveness analysis. The committee adopted the Bliss amendment and then gave HB 2726 a due-pass recommendation by an 8-4 vote. HB 2435, as amended, would create a provisional licensing pathway for internationally trained physicians who meet specified ECFMG-related criteria, with supervision, fees set by the Medical Board, and automatic conversion to a full license after four years if conditions are met. Supporters argued Arizona faces severe physician shortages, especially in rural and tribal areas, and that the bill would bring in experienced doctors while preserving oversight. Opponents, including the Arizona Medical Board, said current law already allows case-by-case licensure review and warned the bill could weaken safeguards and bypass existing scrutiny. After adopting the amendment, the committee approved HB 2435 on a due-pass recommendation. HB 2958 would require Access coverage for comprehensive dental care for pregnant women age 21 and older, with a $500,000 general fund appropriation for a pilot program. The sponsor and public health witnesses said dental care during pregnancy is linked to better maternal and infant outcomes and could reduce emergency room use and complications. The committee adopted the bill and sent it out with an 11-1 due-pass recommendation. HB 2176, which sets timelines and standards for health care institution complaint investigations and dispute resolution, also received broad support from hospitals and was approved unanimously on a 12-0 due-pass recommendation. The committee then heard HB 2447, which would bar insurers from reimbursing certified registered nurse anesthetists at a lower rate than anesthesiologists for the same service. Opponents argued the bill would interfere with private contracting, ignore differences in training and liability, and likely raise costs for the state and taxpayers; supporters said anesthesia demand has outpaced reimbursement and that parity is needed to protect access, especially in rural areas. The transcript ends during testimony on HB 2447, before any vote is taken.

Transcript Highlights:

• Change the Outcome uses evidence-based instruction on opioid dangers, prevention strategies, tips for
• </c><01:07:01.559><c> and</c> experience a devastating opioid and experience a devastating opioid and
• </c><01:09:47.319><c> pre</c><01:09:47.799><c> prevention</c> funding for opioid pre prevention funding
• for opioid pre prevention education<01:09:50.480><c> my</c><01:09:50.640><c> name</c><01:09:50.839><
• We have a very robust opioid prevention and response programs, and the last time I looked, I don't think

Committee: House Health Finance and Policy

Keywords: 1183, house

Transcript Highlights:

• We can prevent hospitalizations.
• So what this bill will do is level the playing field by ensuring opioids and non-opioids are treated
• What this bill will do is level the playing field by ensuring opioids and non-opioids are treated equally
• of opioid addiction versus these non-opioid alternatives.
• expensive non-opioid medications?

Bills: HB2176 , HB2333 , HB2435 , HB2447 , HB2617 , HB2683 , HB2686 , HB2725 , HB2726 , HB2906 , HB2953 , HB2958

Committee: House Health & Human Services

Keywords: health care, licensure, complaints, investigation, safety, patient care, regulatory compliance, prosthetics, orthotics, health insurance, Medicare, medical necessity, disability rights, coverage, reimbursement, internationally trained physicians, medical board, clinical training, provisional license, healthcare workforce